New Strategy Intercepts Pancreatic Cancer by Eliminating Microscopic Lesions Before They Become Cancer Penn Medicine News The latest research at Penn Medicine, led by Drs. Minh Than, Ben Stanger and Robert Vonderheide focuses on targeting the earliest, pre-cancerous changes in the pancreas before the cells developed into pancreatic cancer. Latest News NHGRI-funded Population Genomic Screening Network to Study ‘Full Cycle of Implementation’ Genome Web (Subscription Required) News | July 2026 Basser Center for BRCA Founders Jon and Mindy Gray Bet on AI Science Research to Prevent Cancer Bloomberg (Subscription Required) News | June 2026 Susan G. Komen’s New $15.4M Grant Round Targets AI, Emerging Technologies, and Novel Breast Cancer Therapies Dallas Innovates News | June 2026 Applying Prostate Cancer Genomic Risk in the Clinic Precision Pathology Podcast News | June 2026 New Frontiers in Nipping Cancer in the Bud Penn Medicine News News | June 2026 Support for Trainees Ensures a Bright Future for BRCA Science Penn Medicine News News | June 2026 Conversations in Early Breast Cancer: Survival Outcomes in Patients with BRCA1/2 Mutation MDAlert News | May 2026 ‘Nobody Wants This’ Actress Jackie Tohn Talks Life, Career, BRCA Diagnosis Daily Northwestern News | May 2026 Preclinical Study Addresses a Question: Should RAS Inhibitors Be Given Preemptively for Pancreatic Cancer? ASCO Post News | May 2026 Breast Cancer Driven by Germline TP53 Mutations Springer Nature Research Communities News | May 2026 Should You Get Tested for Lynch Syndrome? Doctissimo News | April 2026 Researchers Explore New Strategy to Stop Pancreatic Cancer Before It Develops Precision Medicine News | April 2026 What You Need To Know About Blood Tests For Cancer Forbes News | March 2026 What’s Lynch Syndrome? The Hidden Genetic Risk Behind Multiple Cancers HuffPost News | March 2026 Penn Medicine Launches King Center for Lynch Syndrome Philadelphia Inquirer News | March 2026 Abramson Cancer Center Director Elected to Lead American Association for Cancer Research Penn Medicine News News | March 2026 Robert H. Vonderheide, MD, DPhil, FAACR, Elected as American Association for Cancer Research President-Elect for 2026-2027 AACR News | March 2026 KRAS Inhibitors Intercept Pancreatic Cancer Before It Develops in Mice Inside Precision Medicine News | March 2026 Pagination Current page1 Page2 Page3 Page4 Page5 Page6 Page7 Page8 Page9 … Next page›› Last pageLast »
New Strategy Intercepts Pancreatic Cancer by Eliminating Microscopic Lesions Before They Become Cancer Penn Medicine News The latest research at Penn Medicine, led by Drs. Minh Than, Ben Stanger and Robert Vonderheide focuses on targeting the earliest, pre-cancerous changes in the pancreas before the cells developed into pancreatic cancer.
NHGRI-funded Population Genomic Screening Network to Study ‘Full Cycle of Implementation’ Genome Web (Subscription Required) News | July 2026
Basser Center for BRCA Founders Jon and Mindy Gray Bet on AI Science Research to Prevent Cancer Bloomberg (Subscription Required) News | June 2026
Susan G. Komen’s New $15.4M Grant Round Targets AI, Emerging Technologies, and Novel Breast Cancer Therapies Dallas Innovates News | June 2026
Conversations in Early Breast Cancer: Survival Outcomes in Patients with BRCA1/2 Mutation MDAlert News | May 2026
‘Nobody Wants This’ Actress Jackie Tohn Talks Life, Career, BRCA Diagnosis Daily Northwestern News | May 2026
Preclinical Study Addresses a Question: Should RAS Inhibitors Be Given Preemptively for Pancreatic Cancer? ASCO Post News | May 2026
Researchers Explore New Strategy to Stop Pancreatic Cancer Before It Develops Precision Medicine News | April 2026
Abramson Cancer Center Director Elected to Lead American Association for Cancer Research Penn Medicine News News | March 2026
Robert H. Vonderheide, MD, DPhil, FAACR, Elected as American Association for Cancer Research President-Elect for 2026-2027 AACR News | March 2026
KRAS Inhibitors Intercept Pancreatic Cancer Before It Develops in Mice Inside Precision Medicine News | March 2026
